Covalon, AVA Unite to Prevent IV Infection Risks
MISSISSAUGA, Ontario, Feb. 19, 2026 — Covalon Technologies Ltd. announced a strategic educational collaboration with the Association for Vascular...
Patient Safety
Advertisement
FDA Clears Argos Infinity for Advanced Cardiac Monitoring
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
Amlodipine Recall Issued Over Wrong Drug Risk
Ottawa, Canada — February 6, 2026 Health authorities have issued a public advisory announcing the recall of two lots...
Cardiology Claims Review Highlights Malpractice Risk Trends
NAPA, Calif., February 3, 2026 — The Doctors Company, the largest physician-owned medical malpractice insurer in the United States,...
IceCure Receives U.S. Patent Allowance for XSense Cryoprobe Technology
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
Advertisements
Precision Tablet Manufacturing Improved at Piramal’s Morpeth Facility
September 16, 2025 — Morpeth, United Kingdom Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO),...
Bio-Thera and STADA Expand Alliance with Biosimilars-Tocilizumab
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
FDA Recalls Frozen Shrimp Because of Possible Health Risk
August 21, 2025: The U.S. Food and Drug Administration (FDA) has issued a public health advisory cautioning against consumption,...
SmartAlpha’s Ultrasound AI Software Nerveblox Gains FDA 510(k) Approval
ANKARA, Türkiye, August 18, 2025 — SmartAlpha’s AI-powered software, Nerveblox, designed to assist clinicians performing ultrasound-guided regional anesthesia (“nerve...
Advertisement
